Showing results (111-120 of 188) with videos related to

Sort By:
Pageof 19
Blood|November 15, 1990
Serum soluble interleukin-2 receptor is associated with clinical and pathologic disease status in hairy cell leukemiaJ M Richards, R Mick, J M Latta, et al.
Clinical Pharmacology and Therapeutics|May 26, 1999
Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphismL Iyer, D Hall, S Das, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 27, 2013
Nonlinear population pharmacokinetics of sirolimus in patients with advanced cancerK Wu, E E W Cohen, L K House, et al.
Clinical and Experimental Dermatology|July 11, 2006
Inflammation of actinic keratoses subsequent to therapy with sorafenib, a multitargeted tyrosine-kinase inhibitorM E Lacouture, A Desai, K Soltani, et al.
Clinical Pharmacology and Therapeutics|August 30, 2012
The 1200 patients project: creating a new medical model system for clinical implementation of pharmacogenomicsP H O'Donnell, A Bush, J Spitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Study of cohort-specific consent and patient control in phase I cancer trialsC K Daugherty, M J Ratain, H Minami, et al.
Clinical Pharmacology and Therapeutics|March 5, 2016
Disease-drug database for pharmacogenomic-based prescribingS Hussain, B B Kenigsberg, K Danahey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
Population pharmacodynamic study of amonafide: a Cancer and Leukemia Group B studyM J Ratain, G Rosner, S L Allen, et al.
Clinical Pharmacology and Therapeutics|March 1, 1996
Etoposide combined with interferon alfa-2b: novel exploitation of established etoposide pharmacokinetics and pharmacodynamicsR Mick, E E Vokes, T M Lestingi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
5-Fluorouracil, leucovorin, hydroxyurea, and escalating doses of continuous-infusion cisplatin with concomitant radiotherapy: a clinical and pharmacologic studyE E Vokes, J A Moormeier, M J Ratain, et al.
Pageof 19